2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow Postmenopausal Osteoporosis: new trials by email Literature Review of Postmenopausal Osteoporosis trials Research Report on Postmenopausal Osteoporosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for Fracture LY06006 - Postmenopausal Osteoporosis | Phase 3 | Unknown | Luye Pharma Group Ltd. | 448 | 2019-06-30 | 2021-09-29 |
| Efficacy and Safety of QL1206 in the Treatment of Postmenopausal Osteoporosis With High Fracture Risk QL1206, Placebos - Postmenopausal Osteoporosis | Phase 3 | Unknown | Qilu Pharmaceutical Co., Ltd. | 440 | 2019-06-05 | 2019-11-06 |
Osteoporosis, Postmenopausal (2)
Bone Diseases (2) · Bone Diseases, Metabolic (2) · Metabolic Diseases (2) · Musculoskeletal Diseases (2) · Nutritional and Metabolic Diseases (2) · Osteoporosis (2)
QL1206 (1)
Luye Pharma Group Ltd. (1) · Qilu Pharmaceutical Co., Ltd. (1)
China (2)